相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
Yuxin Zhao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma
Paula Aldaz et al.
CANCERS (2021)
Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice
Karthik Ravi et al.
LEUKEMIA & LYMPHOMA (2021)
Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies
Giuseppe Nicolo Fanelli et al.
GENES (2021)
Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs
Maria-Magdalena Georgescu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation
David J. Lundy et al.
PHARMACEUTICS (2021)
Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis
Jianwei Wei et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Local delivery to malignant brain tumors: potential biomaterial-based therapeutic/adjuvant strategies
Majed Alghamdi et al.
BIOMATERIALS SCIENCE (2021)
Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival
Lauren R. Schaff et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Brain accumulation of tivozanib is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein) in mice
Jing Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
HGF/MET Signaling in Malignant Brain Tumors
Elizabeth Qian Xu Mulcahy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mechanisms of EGFR Resistance in Glioblastoma
Peter C. Pan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
The genetic landscape of gliomas arising after therapeutic radiation
Giselle Y. Lopez et al.
ACTA NEUROPATHOLOGICA (2019)
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Niklas Schaefer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation
Hamza Saleem et al.
DRUG RESISTANCE UPDATES (2019)
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations
Vidyalakshmi Chandramohan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma
Monica Fedele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
Raghupathy Vengoji et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines
Oana Alexandru et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis
C. -H. Heldin et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model
Etienne Audureau et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Pharmacokinetic Assessment of Cooperative Efflux of the Multitargeted Kinase Inhibitor Ponatinib Across the Blood-Brain Barrier
Janice K. Laramy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Multidimensional communication in the microenvirons of glioblastoma
Marike L. Broekman et al.
NATURE REVIEWS NEUROLOGY (2018)
A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine
Hyun Jung Jun et al.
NATURE COMMUNICATIONS (2018)
PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines
Estefania Carrasco-Garcia et al.
CELLS (2018)
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
Huimin Hu et al.
CELL (2018)
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
Carman K. M. Ip et al.
NATURE COMMUNICATIONS (2018)
Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
Tatjana Wallmann et al.
ISCIENCE (2018)
A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses
Natividad Gomez-Roman et al.
NEURO-ONCOLOGY (2017)
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
Myra E. van Linde et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Insulin-Mediated Signaling Facilitates Resistance to PDGFR Inhibition in Proneural hPDGFB-Driven Gliomas
Damian A. Almiron Bonnin et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Brain Accumulation of Ponatinib and Its Active Metabolite, N-Desmethyl Ponatinib, Is Limited by P-Glycoprotein (P-GP/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2)
Anita Kort et al.
MOLECULAR PHARMACEUTICS (2017)
Silencing platelet-derived growth factor receptor-β enhances the radiosensitivity of C6 glioma cells in vitro and in vivo
Ji-Dong Hong et al.
ONCOLOGY LETTERS (2017)
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
Joerg Felsberg et al.
CLINICAL CANCER RESEARCH (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma
Yufang Ma et al.
CLINICAL CANCER RESEARCH (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Corticosteroids compromise survival in glioblastoma
Kenneth L. Pitter et al.
BRAIN (2016)
Emerging targeted therapies for glioma
Julie J. Miller et al.
EXPERT OPINION ON EMERGING DRUGS (2016)
Clonal evolution of glioblastoma under therapy
Jiguang Wang et al.
NATURE GENETICS (2016)
A comprehensive profile of recurrent glioblastoma
B. Campos et al.
ONCOGENE (2016)
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
Carl Koschmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN- glioblastoma in vivo
Wen Xu et al.
ONCOTARGET (2016)
The Complexity of the ERK/MAP-Kinase Path way and the Treatment of Melanoma Skin Cancer
Claudia Wellbrock et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
KD019: Blood brain barrier penetrant HER2/neu, Src, and EGFR inhibitor
James R. Tonra et al.
CANCER RESEARCH (2015)
Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1)
Anita Kort et al.
PHARMACEUTICAL RESEARCH (2015)
Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients
Lisa B. E. Shields et al.
RADIATION ONCOLOGY (2015)
Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways
Harish N. Vasudevan et al.
ELIFE (2015)
OPINION Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
Frank B. Furnari et al.
NATURE REVIEWS CANCER (2015)
Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma
Tatsuya Ozawa et al.
CANCER CELL (2014)
PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment
Carlo Cenciarelli et al.
MOLECULAR CANCER (2014)
The epidemiology of glioma in adults: a state of the science review
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations
A. I. Velghe et al.
ONCOGENE (2014)
Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
David A. Nathanson et al.
SCIENCE (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
Mark A. Lemmon et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
Joshua M. Francis et al.
CANCER DISCOVERY (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy
Devron R. Shah et al.
DRUG SAFETY (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structural and Functional Properties of Platelet-Derived Growth Factor and Stem Cell Factor Receptors
Carl-Henrik Heldin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients
David Akhavan et al.
CANCER DISCOVERY (2013)
Pharmacokinetic Assessment of Efflux Transport in Sunitinib Distribution to the Brain
Rajneet K. Oberoi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling
Salvatore J. Coniglio et al.
MOLECULAR MEDICINE (2012)
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
Nicholas J. Szerlip et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Devendra Singh et al.
SCIENCE (2012)
Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma
Janna Paulsson et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas
Tatsuya Ozawa et al.
GENES & DEVELOPMENT (2010)
Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme
Matthias Holdhoff et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo
Lei Han et al.
MEDICAL ONCOLOGY (2010)
Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
Kimmo J. Hatanpaa et al.
NEOPLASIA (2010)
Characteristics of compounds that cross the blood-brain barrier
William A. Banks
BMC NEUROLOGY (2009)
Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing
Jason T. Huse et al.
BRAIN PATHOLOGY (2009)
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
O. Martinho et al.
BRITISH JOURNAL OF CANCER (2009)
De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
Stephen M. Wiesner et al.
CANCER RESEARCH (2009)
Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects
Joerg Thomas Hartmann et al.
CURRENT DRUG METABOLISM (2009)
GFAP Promoter Driven Transgenic Expression of PDGFB in the Mouse Brain Leads to Glioblastoma in a Trp53 null Background
Sanna-Maria Hede et al.
GLIA (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
Haihao Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Modeling Adult Gliomas Using RCAS/t-va Technology
Dolores Hambardzumyan et al.
TRANSLATIONAL ONCOLOGY (2009)
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
Kimmo Porkka et al.
BLOOD (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Iatrogenic immunosuppression in patients with newly diagnosed high-grade gliomas
S. A. Grossman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials
Kathryn A. Carson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients
J. -F. Mineo et al.
ACTA NEUROCHIRURGICA (2007)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
Structural basis of hepatocyte growth factor/scatter factor and MET signalling
E Gherardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
RNA interference against a glioma-derived allele of EGFR induces blockade at G2M
QW Fan et al.
ONCOGENE (2005)
Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells
H Takeuchi et al.
BRITISH JOURNAL OF CANCER (2004)
Gene expression profiling of gliomas strongly predicts survival
WA Freije et al.
CANCER RESEARCH (2004)
Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor
E Gherardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression profiling identifies molecular subtypes of gliomas
R Shai et al.
ONCOGENE (2003)
Identification of molecular subtypes of glioblastoma by gene expression profiling
PS Mischel et al.
ONCOGENE (2003)
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
C Dai et al.
GENES & DEVELOPMENT (2001)
分享论文
